I think they are pursuing a long hauler study beca
Post# of 148176
1. No enrollment issues
2. Based on data from cd10, they believe efficacy will be through the roof. Dr. Kelly alluded to this. Perhaps they noticed no long term brain fog in any leronlimab patients from post trial follow-up exams?
3. There are no cheap, available drugs for cognitive long hauler symptoms.
4. Very short timeline.
5. No other trials addressing long haulers.
6. They already have a head start from studies & observations by Dr. Recknor who himself was a cured long hauler.